INTS Intensity Therapeutics, Inc.
3.800USD+7.04%Mkt Cap: 12.41M $P/E: —1d ago
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead produc…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap12.41M USD
Enterprise Value2.16M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.61M USD
Revenue/Share—
Last Price3.800 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.78
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.13
EPS (TTM)-3.88
EPS (Forward)-1.99
52W Range
3.2101% of range43.50
52W High43.50 USD
52W Low3.210 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-97.73%
ROA-82.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.23M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-50.63%
Net Debt-9.43M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.01
Current Ratio5.00
Quick Ratio4.25
Book Value/Sh3.13 USD
Cash/Share2.92 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateFeb 19, 2026
Analyst Consensus
Rating—
Target (Mean)19.33 USD
Upside (mean)+408.8%
Target Range7.000 USD – 32.00 USD
7.000+408.8% to mean32.00
# Analysts6
Ownership
Shares Out.3.26M
Float3.04M
Insiders3.92%
Institutions36.55%
Short Interest
Short Ratio1.1d
Short % Float1.00%
Short % Out.0.96%
Shares Short31.30K
Short (prev mo.)81.76K
Technical
SMA 504.096 (-7.2%)
SMA 2005.870 (-35.3%)
Beta3.08
S&P 52W Chg16.45%
Avg Vol (30d)20.56K
Avg Vol (10d)18.84K
Technical Indicators
RSI (14)49.1
MACD-0.1763
MACD Signal-0.1736
MACD Hist.-0.0027
BB Upper4.364 USD
BB Middle3.789 USD
BB Lower3.214 USD
BB Width30.34%
ATR (14)0.2658 USD
Vol Ratio (20d)1.05x